(Q33935250)

30 July 2017

Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis (English)

1 reference

30 July 2017

Chlamydia trachomatis

0 references

author name string

Minsheng Xia

1

1 reference

30 July 2017

Robert J Suchland

2

1 reference

30 July 2017

Joli A Carswell

3

1 reference

30 July 2017

John Van Duzer

4

1 reference

30 July 2017

Debra K Buxton

5

1 reference

30 July 2017

Kara Brown

6

1 reference

30 July 2017

David M Rothstein

7

1 reference

30 July 2017

Walter E Stamm

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

1 reference

30 July 2017

49

1 reference

30 July 2017

9

1 reference

30 July 2017

3974-3976

1 reference

Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Development potential of rifalazil

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

rpoB mutation conferring rifampin resistance in Streptococcus pyogenes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Structural mechanism for rifampicin inhibition of bacterial rna polymerase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Identification of enzymes responsible for rifalazil metabolism in human liver microsomes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Rifampin in chlamydial infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195391

Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog

5 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16127086

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.49.9.3974-3976.2005

1 reference

30 July 2017

1 reference

30 July 2017

1 reference